Xerient Pharma
PrivateLast Round
Seed
Feb 1, 2025
Total Funding Raised
$4.17M
Company Overview
Xerient Pharma operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Seed round in February 2025.
Xerient Pharma is a drug discovery company that develops radioprotective therapeutics and diagnostics designed to enhance the effectiveness and safety of pancreatic cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xerient Pharma Comparables
Compare Xerient Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Humanetics Corporation | 70% | |
| Galera Therapeutics | 66% | |
| Clinigen | 63% |
For institutional investors. Book with your work email.
Xerient Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 1, 2025 | ||||
| Seed | Jul 1, 2023 | ||||
| Grant | Jan 19, 2023 | ||||
| Grant | Aug 17, 2022 | ||||
| Seed | Mar 30, 2020 |
For institutional investors. Book with your work email.
Xerient Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BIRD Foundation | Grant |
| Southern Israel Bridging Fund | Seed |
| NewTech Investment Holdings | Seed |
| Peregrine Ventures | Seed |
| Incentive Incubator | Seed |
| Cancer Prevention and Research Institute of Texas | Grant |
Xerient Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xerient Pharma's valuation, stock price, and market status.
Is Xerient Pharma a public or private company?
Xerient Pharma is a private company.
What is the current stock price of Xerient Pharma?
Xerient Pharma is a private company, so its shares have no public market price. Caplight tracks Xerient Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xerient Pharma worth (valuation)?
Valuation information for Xerient Pharma is not publicly available.
Can I buy Xerient Pharma stock?
Xerient Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xerient Pharma's last funding round?
Xerient Pharma's most recent funding round was Seed on February 1, 2025.
Who are the main investors in Xerient Pharma?
Key investors in Xerient Pharma include BIRD Foundation, Southern Israel Bridging Fund, NewTech Investment Holdings, Peregrine Ventures, Incentive Incubator.
Will Xerient Pharma IPO soon?
No public IPO plans have been announced for Xerient Pharma.
How can I track Xerient Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Xerient Pharma's shares on secondary markets.